KDM4B and breast carcinoma: Since many of the estrogen-induced genes that regulate breast cancer proliferation and progression are also regulated by hypoxia (Cyclin D1, WISP2, etc.), KDM4B serves to integrate two known drivers of breast cancer progression [40].